Go to content
DSM B.V.

DSM B.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 11 mrt 2009 - 14:27
Statutaire naam DSM B.V.
Titel DSM obtains exclusive world-wide license for innovative drug delivery technology
Bericht Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologics delivery system developed by MediVas LLC. Integrated into DSM’s Trancerta® Drug Delivery platform, this will open up a broad range of opportunities for next generation drug delivery. DSM’s activities in this field are an illustration of the way DSM is leveraging its competences in Materials Sciences into Life Sciences applications.

Datum laatste update: 12 februari 2025